Henk-Jan Guchelaar

All papers authored by Henk-Jan Guchelaar

This paper is made freely available by the publisher.

2022 Iris Lafeber

, Elisabeth J. Ruijgrok, Henk-Jan Guchelaar

, Kirsten J. M. Schimmel

3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review

Download from doi.org

2021 Lisanne E. N. Manson

, Wilbert B. van den Hout, Henk-Jan Guchelaar

Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Maaike van der Lee

, Henk-Jan Guchelaar

, Jesse J. Swen

Substrate specificity of CYP2D6 genetic variants

Upload

Essra Youssef

, Charlotte L. Kirkdale, David J. Wright

, Henk‐Jan Guchelaar

, Tracey Thornley

Estimating the potential impact of implementing pre‐emptive pharmacogenetic testing in primary care across the UK

Upload

2020 Maaike van der Lee

, Marjolein Kriek, Henk-Jan Guchelaar

, Jesse J. Swen

Technologies for Pharmacogenomics: A Review

Download from doi.org

Sylvia D. Klomp

, Martijn L. Manson

, Henk-Jan Guchelaar

, Jesse J. Swen

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

Download from doi.org

Cathelijne H. van der Wouden, Ellen Paasman, Martina Teichert

, Matty R. Crone, Henk-Jan Guchelaar

, Jesse J. Swen

Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework

Download from doi.org

2019 M. Y. E. C. Stoep, M. Y. E. C. van der Stoep

, J. Zwaveling

, A. Bertaina

, F. Locatelli, H. J. Guchelaar

, A. C. Lankester

, D. J. A. R. Moes

Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Cathelijne H. Wouden

, Mandy H. van Rhenen, Wafa O. M. Jama, Magnus Ingelman‐Sundberg

, Volker M. Lauschke

, Lidija Konta, Matthias Schwab

, Jesse J. Swen

, Henk‐Jan Guchelaar

Development of the PG x‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Upload

Cathelijne H. van der Wouden

, Paul C. D. Bank, Kübra Özokcu, Jesse J. Swen

, Henk-Jan Guchelaar

Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact

Download from doi.org

A. B. Sanchez-Spitman, J. J. Swen

, V. O. Dezentje, D. J. A. R. Moes, H. Gelderblom, H. J. Guchelaar

Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen

Upload

Athina Spiliopoulou

, Marco Colombo, Darren Plant, Nisha Nair, Jing Cui, Marieke Jh Coenen

, Katsunori Ikari, Hisashi Yamanaka, Saedis Saevarsdottir, Leonid Padyukov, S. Louis Bridges Jr., Robert P. Kimberly, Yukinori Okada, Piet L. Cm van Riel, Gertjan Wolbink and 17 other authors

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39

Upload

Carin A. T. C. Lunenburg, Henk-Jan Guchelaar

, Ron H. N. van Schaik, Michael Neumaier, Jesse J. Swen

Confirmation practice in pharmacogenetic testing; how good is good enough?

Upload

Rineke Gordijn, Martina Teichert, Melianthe P. J. Nicolai, Henk W. Elzevier, Henk-Jan Guchelaar

Adverse drug reactions on sexual functioning: a systematic overview

Upload

Karel K. M. Koudijs, Anton G. T. Terwisscha van Scheltinga, Stefan Böhringer, Kirsten J. M. Schimmel, Henk-Jan Guchelaar

The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples

Download from doi.org

Michiel C. Verboom, Jacqueline S. L. Kloth, Jesse J. Swen

, Stefan Sleijfer, Anna K. L. Reyners, Neeltje Steeghs, Ron H. J. Mathijssen, Hans Gelderblom, Henk-Jan Guchelaar

Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors

Upload

Linda M. Henricks, Carin A. T. C. Lunenburg, Annemieke Cats, Ron H. J. Mathijssen, Henk-Jan Guchelaar

, Jan H. M. Schellens

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? – Authors' reply

Upload

Reinier L. Sluiter, Corine van Marrewijk, Dirk de Jong, Hans Scheffer, Henk-Jan Guchelaar

, Luc Derijks, Dennis R. Wong, Piet Hooymans, Sita H. Vermeulen, Gert Jan van der Wilt, André L. M. Verbeek, Barbara Franke, Wietske Kievit, Marieke J. H. Coenen

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

Upload

Anabel Sanchez-Spitman, Vincent Dezentjé, Jesse Swen

, Dirk Jan A. R. Moes, Stefan Böhringer, Erdogan Batman, Edith van Druten, Carolien Smorenburg, Aart van Bochove, Anneke Zeillemaker, Lynn Jongen, Maartje Los, Patrick Neven, Hans Gelderblom, Henk-Jan Guchelaar

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Henk-Jan Guchelaar